| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |